Rhinovirus Replication in Human Macrophages Induces NF-κB-Dependent Tumor Necrosis Factor Alpha Production
暂无分享,去创建一个
[1] K. Akagawa. Functional Heterogeneity of Colony-Stimulating Factor-Induced Human Nonocyte-Derived Macrophages , 2002, Respirology.
[2] P. Howarth,et al. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. , 2005, Thorax.
[3] D. Proud,et al. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[4] S. Johnston,et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.
[5] J. Auwerx,et al. The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation , 1991, Experientia.
[6] B. Kirby,et al. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. , 2005, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.
[7] S. Johnston,et al. PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. , 2004, Journal of molecular biology.
[8] D. Hommes,et al. New cytokine therapeutics for inflammatory bowel disease. , 2004, Cytokine.
[9] J. Gern,et al. Rhinovirus 3C protease precursors 3CD and 3CD' localize to the nuclei of infected cells. , 2004, The Journal of general virology.
[10] Shu-Jen Chen,et al. Selective human enterovirus and rhinovirus inhibitors: An overview of capsid‐binding and protease‐inhibiting molecules , 2004, Medicinal research reviews.
[11] I. Adcock,et al. Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. , 2004, American journal of respiratory cell and molecular biology.
[12] S. Johnston,et al. Host defense function of the airway epithelium in health and disease: clinical background , 2003, Journal of leukocyte biology.
[13] M. Abe,et al. Rhinovirus 16 3C Protease Induces Interleukin-8 and Granulocyte-Macrophage Colony-Stimulating Factor Expression in Human Bronchial Epithelial Cells , 2004, Pediatric Research.
[14] M. Gersten,et al. Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers , 2003, Antimicrobial Agents and Chemotherapy.
[15] V. Imbert,et al. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells , 2003, Oncogene.
[16] D. Wilkes,et al. Refractory sarcoidosis responding to infliximab. , 2003, Chest.
[17] W. Busse,et al. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. , 2003, American journal of respiratory cell and molecular biology.
[18] F. Kishi,et al. Functional heterogeneity of colony‐stimulating factor‐induced human monocyte‐derived macrophages , 2006, International journal of hematology.
[19] S. Johnston,et al. Reducing agents inhibit rhinovirus‐induced up‐regulation of the rhinovirus receptor intercellular adhesion molecule‐1 (ICAM‐1) in respiratory epithelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[21] Timothy Ravasi,et al. The mononuclear phagocyte system revisited , 2002, Journal of leukocyte biology.
[22] N. Papadopoulos,et al. Rhinovirus‐induced alterations on peripheral blood mononuclear cell phenotype and costimulatory molecule expression in normal and atopic asthmatic subjects , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[23] N. Papadopoulos,et al. A defective type 1 response to rhinovirus in atopic asthma , 2002, Thorax.
[24] W. Busse,et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. , 2002, The Journal of infectious diseases.
[25] R C Read,et al. Macrophage defences against respiratory tract infections. , 2002, British medical bulletin.
[26] D. Laskin,et al. Functional heterogeneity in liver and lung macrophages , 2001, Journal of leukocyte biology.
[27] P. Thomas. Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma , 2001 .
[28] M. Yoneyama,et al. Induction of IRF‐3/‐7 kinase and NF‐κB in response to double‐stranded RNA and virus infection: common and unique pathways , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[29] S. Paludan,et al. Molecular Pathways in Virus-Induced Cytokine Production , 2001, Microbiology and Molecular Biology Reviews.
[30] K. Wright,et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[31] P. Thomas. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. , 2001, Immunology and cell biology.
[32] V. Casolaro,et al. Role of NF-κB in Cytokine Production Induced from Human Airway Epithelial Cells by Rhinovirus Infection1 , 2000, The Journal of Immunology.
[33] R. Panettieri,et al. Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma? , 2000, Respiratory research.
[34] P. Dragovich,et al. Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor , 2000, Antimicrobial Agents and Chemotherapy.
[35] V. Casolaro,et al. Role of NF-kB in Cytokine Production Induced from Human Airway Epithelial Cells by Rhinovirus Infection , 2000 .
[36] Joan Wilson,et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[37] S. Amar,et al. Differentiation of Monocytes to Macrophages Primes Cells for Lipopolysaccharide Stimulation via Accumulation of Cytoplasmic Nuclear Factor κB , 1999, Infection and Immunity.
[38] S. Johnston,et al. Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.
[39] O. Majdic,et al. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. , 1999, The Journal of clinical investigation.
[40] P. Hart,et al. Differential responses of human monocytes and macrophages to IL‐4 and IL‐13 , 1999, Journal of leukocyte biology.
[41] M. Kurimoto,et al. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. , 1999, Journal of immunology.
[42] M. Schroth,et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. , 1999, American journal of respiratory cell and molecular biology.
[43] S. Johnston,et al. Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.
[44] J. Gliemann,et al. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. , 1998, Biological chemistry.
[45] S. Johnston,et al. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. , 1998, Journal of immunology.
[46] M. Yamaya,et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[47] S. Johnston,et al. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. , 1997, The Journal of infectious diseases.
[48] B. Aggarwal,et al. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[49] W. Busse,et al. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. , 1996, Journal of immunology.
[50] P. Barnes,et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.
[51] Weiliang Tang,et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. , 1996, The Journal of clinical investigation.
[52] W. Busse,et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. , 1996, Journal of immunology.
[53] R. Maini,et al. Anti-cytokine therapy in rheumatoid arthritis. , 1995, Bailliere's clinical rheumatology.
[54] R. Silverman,et al. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. , 1995, The Journal of clinical investigation.
[55] Stephen T Holgate,et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.
[56] F. Hayden,et al. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. , 1995, The Journal of infectious diseases.
[57] W. Busse,et al. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. , 1994, The Journal of clinical investigation.
[58] S. Johnston,et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. , 1994, American journal of respiratory cell and molecular biology.
[59] K. Nicholson,et al. Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.
[60] A. Villani,et al. Restricted replication of respiratory syncytial virus in human alveolar macrophages. , 1993, The Journal of general virology.
[61] K. Tracey,et al. Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.
[62] S. Mohla,et al. Phorbol myristate acetate-differentiated THP-1 cells display increased levels of MHC class I and class II mRNA and interferon-gamma-inducible tumoricidal activity. , 1993, Oncology research.
[63] R. Furth. Production and migration of monocytes and kinetics of macrophages , 1992 .
[64] C. Jongeneel,et al. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. , 1991, Journal of immunology.
[65] D. Gemsa,et al. Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. , 1990, Journal of immunology.
[66] C V Jongeneel,et al. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.
[67] M. Auger. Mononuclear phagocytes. , 1989, BMJ.
[68] K. Tada,et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. , 1982, Cancer research.
[69] C. Mims,et al. Influenza virus replication in human alveolar macrophages , 1982, Journal of medical virology.